Richard M Goldberg M.D. Klotz Family Chair in Cancer Research Professor and James Cancer Hospital Physician-in-Chief The Ohio State University Cancer of.
Question: Should genome sequencing of multiple oncogenes surplant BRAF V600 mutation testing by an FDA approved test? Answer: Yes Jeffrey A Sosman MD Ingram.
